Madrigal Pharmaceuticals, Inc. (MDGL)
582.07
-1.66
(-0.28%)
USD |
NASDAQ |
Dec 31, 16:00
582.34
+0.27
(+0.05%)
After-Hours: 19:53
Madrigal Pharmaceuticals Total Liabilities (Quarterly): 736.72M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Eli Lilly & Co. | 91.08B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Amicus Therapeutics, Inc. | 638.39M |
| Insmed, Inc. | 1.415B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.362B |
| Shareholders Equity (Quarterly) | 625.73M |
| Debt to Equity Ratio | 0.5536 |
| Current Ratio | 3.441 |
| Net Debt Paydown Yield | -0.44% |